Funding for this research was provided by:
Pfizer
Article History
Received: 22 May 2024
Accepted: 12 July 2024
First Online: 26 July 2024
Declarations
:
: Johnna Perdrizet and Mark Rozenbaum are employees of Pfizer Inc., manufacturer of the PCV20 vaccine. Matthew Heffler is an employee of Ipsos Insight LLC, which was a paid consultant to Pfizer in connection with the development of this manuscript and conducting this research study.
: This study was conducted in full conformance with the guidelines for good pharmacoepidemiology practice (GPP) published by the International Society of Pharmacoepidemiology (ISPE), the Helsinki Declaration of 1964, and the laws and regulations of the countries in which the research was conducted. Informed consent was collected from all participants prior to participating in the study. No identifiable data were collected during the course of this research or are included in this manuscript. The study (protocol # 2023–0381) was approved by Pearl Institutional Review Board (IRB) of Indianapolis, Indiana, on October 27, 2023. This article is based on primary data collected in human participants who consented to the study.